Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, which aim to optimize treatments and outcomes for individual patients. Metabolite diagnostics empower therapeutic selection, treatment effectiveness monitoring, disease diagnosis, and target identification across indications and therapeutics areas, including oncology, solid-organ transplant, and neurodegeneration. Our mission is to remove the guesswork from medicine.
| Website | https://www.myolaris.com/ |
| Revenue | $3 million |
| Employees | 18 (10 on RocketReach) |
| Founded | 2013 |
| Address | 175 Crossing Boulevard Suite 410, Framingham, Massachusetts 01702, US |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Precision Medicine, Personalized Medicine, Diagnostic Testing, Metabolomics, Patient Outcomes, Clinical Diagnostics, Machine Learning, Treatment Optimization, Therapeutic Development, Predictive Diagnostics, Biomarker Discovery, Health Analytics, Drug Discovery, Medical Technology, Data Analytics, Biotechnology, Healthcare Technology, Systems Biology |
| Competitors | McKesson, IBM, Philips, Optum, Verily, LifeBridge Health, CureMetrix, Oracle Health Information, Epic, CLINICAL REVIEW SOLUTIONS LTD +46 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Olaris, Inc employee's phone or email?
The Olaris, Inc annual revenue was $3 million in 2026.
Tom Burke is the Chief Operating Officer and Chief Financial Officer of Olaris, Inc.
10 people are employed at Olaris, Inc.
Olaris, Inc is based in Framingham, Massachusetts.
The NAICS codes for Olaris, Inc are [54, 541, 5417].
The SIC codes for Olaris, Inc are [87, 873].